Former U.S. President Joe Biden, 82, has been diagnosed with an aggressive form of prostate cancer that has metastasized to his bones, according to a statement released by his office on May 18, 2025. The diagnosis followed the discovery of a small nodule during a routine physical exam, prompted by increasing urinary symptoms. Subsequent tests confirmed a Gleason score of 9 (Grade Group 5), indicating a highly aggressive and fast-growing cancer.
Despite the severity, Biden’s medical team has indicated that the cancer is hormone-sensitive, allowing for potentially effective management through treatments such as hormone therapy, chemotherapy, or radiation. Biden and his family are currently reviewing treatment options with his physicians.
In a public statement, Biden expressed gratitude for the outpouring of support, stating, “Cancer touches us all. Like so many of you, Jill and I have learned that we are strongest in the broken places. Thank you for lifting us up with love and support.”
The diagnosis has prompted responses from prominent figures, including former President Donald Trump and former Vice President Kamala Harris, who both shared messages of support and wished him a speedy recovery.
Biden’s diagnosis underscores the importance of regular health screenings, particularly for older adults. Prostate cancer is the most common cancer among men, with over 300,000 U.S. cases annually. While early-stage prostate cancer has a high five-year survival rate, advanced stages have a significantly lower prognosis.
